Zenith Drugs is a pharmaceutical manufacturing and trading company based out of Indore. They have a manufacturing unit, dedicated to ensuring the highest quality standards when it comes to manufacturing of medicines. They are specialized in manufacturing high-quality and affordable Medicines to support their patients in need. The Company is also into Generic Medicines and Generic Medicines are cost effective. Since its inception, the company has focused on building a strong foundation and laying the groundwork for its future growth and success.
With dedication and strategic planning, they managed to establish a reputable presence in the pharmaceutical industry. The Company was incorporated with the objective of better service deliverance in the field of medicine and being a better premium pharmaceutical company in India and abroad for cost-effective human medicine. The Company always emphasis on core strengths and policies that focus on technology and great deliverance. With a passion for setting high standards of services, the company has always taken all measures to scale up as and when required only to deliver the best. They work diligently and have a wide range of products to cater to every need and to reach the client’s sensitivity and centricity.
They are proud to be WHO-GMP compliant, adhering to the stringent guidelines set by the World Health Organization. Their commitment to quality is further demonstrated by their ISO 9001:2015 certification, obtained from a respected EuroUK certification body. Zenith offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, and Capsules.
Objects of the Issue:
- Purchase of Machinery & Equipments for Setting up New Unit.
- Existing Manufacturing Block Upgradation
- Working Capital Requirements
- General Corporate Purposes.
Zenith Drugs IPO Review
- May Apply
Zenith Drugs IPO Date & Price Band Details
| IPO Open: | February 19, 2024 |
| IPO Close: | February 22, 2024 |
| IPO Size: | Approx ₹40.68 Crores, 5,148,800 Equity Shares |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹75 to ₹79 Per Equity Share |
| IPO Listing on: | NSE SME |
| Retail Quota: | 35% of the net offer |
| QIB Quota: | 50% of the net offer |
| NII Quota: | 15% of the net offer |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors in IPO: | Click Here |
Zenith Drugs IPO Market Lot
The Zenith Drugs IPO minimum market lot is 1600 shares with a ₹126,400 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 1600 | ₹126,400 |
| Retail Maximum | 1 | 1600 | ₹126,400 |
| S-HNI Minimum | 2 | 3200 | ₹252,800 |
Zenith Drugs IPO Dates
The Zenith Drugs IPO date is February 19 and the IPO close date is February 22. The IPO allotment date is February 23 and the IPO might list on February 27.
| IPO Open Date: | February 19, 2024 |
| IPO Close Date: | February 22, 2024 |
| Basis of Allotment: | February 23, 2024 |
| Refunds: | February 26, 2024 |
| Credit to Demat Account: | February 26, 2024 |
| IPO Listing Date: | February 27, 2024 |
You can check IPO subscription status and IPO allotment status on their respective pages.
Zenith Drugs IPO Form
How to apply Zenith Drugs IPO? You can apply Zenith Drugs IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Zenith Drugs IPO in the Invest section. The other option you can apply Zenith Drugs IPO via IPO forms download via the NSE website. Check out the Zenith Drugs forms – click NSE IPO Forms download, fill and submit in your bank or with your broker.
Zenith Drugs Company Financial Report
| ₹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2021 | ₹73.53 | ₹66.37 | ₹3.03 |
| 2022 | ₹92.67 | ₹84.82 | ₹3.13 |
| 2023 | ₹115.70 | ₹104.85 | ₹5.15 |
| Sep 2023 | ₹69.48 | ₹59.79 | ₹5.39 |
Zenith Drugs IPO Valuation – FY2023
Check Zenith Drugs IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Earning Per Share (EPS): | ₹128.83 per Equity Share |
| Price/Earning P/E Ratio: | 17.48 |
| Return on Net Worth (RoNW): | 431.10% |
| Net Asset Value (NAV): | ₹14.37 per Equity Share |
Peer Group
- Sudarshan Pharma Industries Limited
- Sigachi Industries Limited
Company Promoters
- Mr. Sandeep Bhardwaj
- Mr. Bhupesh Soni
- Mr. Ajay Singh Dassundi
Zenith Drugs IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: [email protected]
Website: http://www.bigshareonline.com
Zenith Drugs IPO Allotment Status
Check Zenith Drugs IPO allotment status on Bigshare website URL. Click Here
Zenith Drugs IPO Lead Managers aka Merchant Bankers
- Gretex Corporate Services Limited
Company Address
Zenith Drugs Limited
K. No. 72 / 5, Village Muradpura
NA Depalpur,
Indore-453001
Phone: +91 8435501867
Email: [email protected]
Website: https://zenithdrugs.com/
